Results 251 to 260 of about 64,955 (305)
Some of the next articles are maybe not open access.

Complications of SSRI Treatment

Journal of Child and Adolescent Psychopharmacology, 2001
EVEN THOUGH THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) have a very favorable side-effect profile, problems can develop during treatment that can cause concern. Complications of treatment that are easiest to deal with are those that are expected, occur early in the course of treatment, are mostly physical in nature, and either go away on their ...
J, Walkup, M, Labellarte
openaire   +2 more sources

SSRI-to-SSRI Switching and Associated Dosing Characteristics

Journal of Managed Care Pharmacy, 1999
OBJECTIVE: To evaluate antidepressant switching rates and associated dosing characteristics in patients undergoing therapy with one of the selective serotonin reuptake inhibitors (SSRls)-fluoxetine, paroxetine, or sertraline. DESIGN: A longitudinal, retrospective drug utilization analysis of administrative prescription claims for patients who initiated
openaire   +1 more source

SSRIs and conditioned fear

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
Among drugs that act on serotonergic neurotransmission, selective serotonin (5-HT) reuptake inhibitors (SSRIs) are now the gold standard for the treatment of anxiety disorders. The precise mechanisms of the anxiolytic actions of SSRIs are unclear.
Takeshi, Inoue   +2 more
openaire   +2 more sources

SSRIs: Are the accusations justified

The World Journal of Biological Psychiatry, 2004
(2004). SSRIs: Are the accusations justified. The World Journal of Biological Psychiatry: Vol. 5, No. 4, pp. 174-175.
openaire   +2 more sources

The SSRI discontinuation syndrome

Journal of Psychopharmacology, 1998
A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome appears to exist. It is usually mild, commences within 1 week of stopping treatment, resolves spontaneously within 3 weeks, and consists of diverse physical and psychological symptoms, the commonest being dizziness, nausea, lethargy and headache. SSRI reinstatement
openaire   +2 more sources

Differences in interactions of SSRIs

International Clinical Psychopharmacology, 1998
The SSRIs differ from each other with regard to their chemical structure, their pharmacokinetics and their potential for causing pharmacokinetic interactions through inhibition of species of the cytochrome P450 enzyme system. Cytochrome P450 (CYP) is a group of more than 30 different heme containing proteins in humans, some of which play a key role in ...
openaire   +2 more sources

SSRIs

2010
Michael M. Morgan   +199 more
openaire   +2 more sources

SSRI’S

Nursing, 2022
openaire   +1 more source

SSRIs and Osteoporosis

Obstetrics & Gynecology, 2008
openaire   +2 more sources

Home - About - Disclaimer - Privacy